PCRX
Pacira Biosciences Stock Analysis
AI Rating
- Quality5/10
- Growth↓ 0/10
- Value↓ 3/10
PCRX Growth
- Revenue Y/Y↑ 12.48%
- EPS Y/Y↑ 105.33%
- FCF Y/Y↓ -16.75%
PCRX Profitability
- Gross margin ↑ 79.30%
- EPS margin↓ 0.70%
- ROIC 5Y↓ 1.82%
PCRX Risk
- Debt / Equity↓ 0.6
- Debt / FCF↓ 2.0
- Interest coverage↓ 1.8
Pacira Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.